UK’ s National Health Service Supply Chain Ranks -- MEDICA - World Forum for Medicine


ZOLL Medical Corporation

UK’ s National Health Service Supply Chain Ranks

September 23, 2008, Chelmsford, Massachusetts and Cheshire, United Kingdom—Zoll Medical Corporation (Nasdaq GS: Zoll), a manufacturer of resuscitation devices and related software solutions, announced today that its new R Series® Code-Ready™ clinical defibrillator has received the highest overall score of all devices evaluated by the United Kingdom’s National Health Service Supply Chain (NHS Supply Chain).

The evaluation was undertaken on behalf of NHS Supply Chain by a panel of highly- experienced end-users and experts from a variety of NHS Trusts. Listing on its National Defibrillator Framework Agreement means that hospitals and EMS agencies no longer need to go through the tender process, but can order the R Series directly from the NHS Supply Chain.

“The fact that the R Series came out on top of all the hospital defibrillators evaluated represents a strong endorsement of ZOLL’s commitment to helping clinicians improve resuscitation outcomes,” said Mark Webster, Managing Director of ZOLL Medical U.K. Ltd. “The R Series incorporates CPR support, code-readiness and data management technologies all in one defibrillator.”

“The R Series features ZOLL’s exclusive technology that sets a new standard for simplicity and operational readiness, which helps improve in-hospital resuscitation efforts,” said Richard A. Packer, Chairman and Chief Executive Officer of ZOLL

ZOLL R Series: Simple, Smart, Ready
The R Series is a Code-Ready device that is simple, smart, and ready to use. It offers a OneStep™ system to simplify and speed up deployment of pacing and defibrillation therapy. It also offers smart tools to help clinicians improve CPR performance, which is important since more than half of in-hospital codes involve non-shockable rhythms and, in such cases, the only treatment is high-quality CPR with minimal interruptions.

The R Series can also verify the condition and expiration date of the electrode set. All of this testing occurs without disconnecting electrodes or paddles, or requiring additional equipment to test shock delivery. The system provides a printed or electronic log to alert hospital personnel of any concerns in advance of a code. A simple green checkmark indicates that the R Series is fully ready for use.


This Framework Agreement became effective in the U.K. on July 8, 2008 for a two-year period with an option to extend the agreement for an additional two years. For details, please contact either Angela Dunigan at the NHS Supply Chain on +44 (0)7767 374967 or your local ZOLL representative on +44 (0)1928 595 160.

About NHS Supply Chain
NHS Supply Chain produces National Framework Agreements which offer the NHS all-round best value for money from a financial and non-financial perspective. Framework Agreements are tendered based on financial and non-financial criteria covering commercial viability around specification, maintenance, warranty, and non-financial areas such as training and maintenance packages, ability to supply and support, and quality and safety. The tender process draws on the resource of experts from the health service from national geographical locations and with their input, the whole tender specification is agreed upon. Tender responses are scored based on the proposals submitted by the suppliers. The ones which offer the most economically advantageous responses that fulfil all the criteria are taken forward.

About ZOLL Medical Corporation
ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies, including Real CPR Help® and See-Thru CPR®, that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information.

ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia. 2008 marks the 25th anniversary of ZOLL’s resuscitation product development. For more information, visit

Copyright © 2008 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. ZOLL, R Series, Real CPR Help, and See-Thru CPR are registered trademarks of ZOLL Medical Corporation. Code-Ready and OneStep are trademarks of ZOLL Medical Corporation. All product names are the property of their respective owners.